SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020-2021.

Piyasena, C; Galu, S; Yoshida, R; Thakkar, D; O'Sullivan, J; Longley, C; Evans, K; Sweeney, S; Kendall, G; Ben-Sasi, K; et al. Piyasena, C; Galu, S; Yoshida, R; Thakkar, D; O'Sullivan, J; Longley, C; Evans, K; Sweeney, S; Kendall, G; Ben-Sasi, K; Richards, J; Harris, C; Jagodzinski, J; Demirjian, A; Lamagni, T; Le Doare, K; Heath, PT; Battersby, C; Neonatal Trainee-Led Research and Improvement Projects (NeoTRIPs (2023) Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020-2021. BMJ Open, 13 (7). e072708. ISSN 2044-6055 https://doi.org/10.1136/bmjopen-2023-072708
SGUL Authors: Le Doare, Kirsty Heath, Paul Trafford

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (669kB) | Preview

Abstract

OBJECTIVE: We sought to compare the incidence of early-onset sepsis (EOS) in infants ≥34 weeks' gestation identified >24 hours after birth, in hospitals using the Kaiser Permanente Sepsis Risk Calculator (SRC) with hospitals using the National Institute for Health and Care Excellence (NICE) guidance. DESIGN AND SETTING: Prospective observational population-wide cohort study involving all 26 hospitals with neonatal units colocated with maternity services across London (10 using SRC, 16 using NICE). PARTICIPANTS: All live births ≥34 weeks' gestation between September 2020 and August 2021. OUTCOME MEASURES: EOS was defined as isolation of a bacterial pathogen in the blood or cerebrospinal fluid (CSF) culture from birth to 7 days of age. We evaluated the incidence of EOS identified by culture obtained >24 hours to 7 days after birth. We also evaluated the rate empiric antibiotics were commenced >24 hours to 7 days after birth, for a duration of ≥5 days, with negative blood or CSF cultures. RESULTS: Of 99 683 live births, 42 952 (43%) were born in SRC hospitals and 56 731 (57%) in NICE hospitals. The overall incidence of EOS (<72 hours) was 0.64/1000 live births. The incidence of EOS identified >24 hours was 2.3/100 000 (n=1) for SRC vs 7.1/100 000 (n=4) for NICE (OR 0.5, 95% CI (0.1 to 2.7)). This corresponded to (1/20) 5% (SRC) vs (4/45) 8.9% (NICE) of EOS cases (χ=0.3, p=0.59). Empiric antibiotics were commenced >24 hours to 7 days after birth in 4.4/1000 (n=187) for SRC vs 2.9/1000 (n=158) for NICE (OR 1.5, 95% CI (1.2 to 1.9)). 3111 (7%) infants received antibiotics in the first 24 hours in SRC hospitals vs 8428 (15%) in NICE hospitals. CONCLUSION: There was no significant difference in the incidence of EOS identified >24 hours after birth between SRC and NICE hospitals. SRC use was associated with 50% fewer infants receiving antibiotics in the first 24 hours of life.

Item Type: Article
Additional Information: © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Keywords: Epidemiology, Neonatal intensive & critical care, Paediatric infectious disease & immunisation, Infant, Newborn, Infant, Humans, Female, Pregnancy, Neonatal Sepsis, Cohort Studies, Prospective Studies, London, Risk Assessment, Sepsis, Anti-Bacterial Agents, Retrospective Studies, Risk Factors, Neonatal Trainee-Led Research and Improvement Projects (NeoTRIPs) group, 1103 Clinical Sciences, 1117 Public Health and Health Services, 1199 Other Medical and Health Sciences
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: BMJ Open
ISSN: 2044-6055
Language: eng
Dates:
DateEvent
27 July 2023Published
10 July 2023Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
PubMed ID: 37500270
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115575
Publisher's version: https://doi.org/10.1136/bmjopen-2023-072708

Actions (login required)

Edit Item Edit Item